135 related articles for article (PubMed ID: 36610224)
1. TGF-β2 antisense oligonucleotide enhances T-cell mediated anti-tumor activities by IL-2 via attenuation of fibrotic reaction in a humanized mouse model of pancreatic ductal adenocarcinoma.
Lee HK; Nam MW; Go RE; Koo J; Kim TH; Park JE; Choi KC
Biomed Pharmacother; 2023 Mar; 159():114212. PubMed ID: 36610224
[TBL] [Abstract][Full Text] [Related]
2. Blockade of transforming growth factor β2 by anti-sense oligonucleotide improves immunotherapeutic potential of IL-2 against melanoma in a humanized mouse model.
Lee HK; Shin HJ; Koo J; Kim TH; Kim CW; Go RE; Seong YH; Park JE; Choi KC
Cytotherapy; 2021 Jul; 23(7):599-607. PubMed ID: 33975794
[TBL] [Abstract][Full Text] [Related]
3. Targeting transforming growth factor-β2 by antisense oligodeoxynucleotide accelerates T cell-mediated tumor rejection in a humanized mouse model of triple-negative breast cancer.
Lee HK; Ji HJ; Shin SK; Koo J; Kim TH; Kim CW; Seong YH; Park JE; Choi KC
Cancer Immunol Immunother; 2022 Sep; 71(9):2213-2226. PubMed ID: 35099588
[TBL] [Abstract][Full Text] [Related]
4. Next-Generation Antisense Oligonucleotide of TGF-β2 Enhances T Cell-Mediated Anticancer Efficacy of Anti-PD-1 Therapy in a Humanized Mouse Model of Immune-Excluded Melanoma.
Lee HK; Kim CW; Ahn D; Go RE; Choi Y; Choi KC
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358638
[TBL] [Abstract][Full Text] [Related]
5. CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer.
Pu N; Zhao G; Yin H; Li JA; Nuerxiati A; Wang D; Xu X; Kuang T; Jin D; Lou W; Wu W
J Transl Med; 2018 Oct; 16(1):294. PubMed ID: 30359281
[TBL] [Abstract][Full Text] [Related]
6. Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression.
Hussain SM; Kansal RG; Alvarez MA; Hollingsworth TJ; Elahi A; Miranda-Carboni G; Hendrick LE; Pingili AK; Albritton LM; Dickson PV; Deneve JL; Yakoub D; Hayes DN; Kurosu M; Shibata D; Makowski L; Glazer ES
Cell Oncol (Dordr); 2021 Jun; 44(3):673-687. PubMed ID: 33694102
[TBL] [Abstract][Full Text] [Related]
7. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract][Full Text] [Related]
8. A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.
Zhang Y; Xu J; Hua J; Liu J; Liang C; Meng Q; Wei M; Zhang B; Yu X; Shi S
J Immunother Cancer; 2019 Aug; 7(1):233. PubMed ID: 31464648
[TBL] [Abstract][Full Text] [Related]
9. Foxp3 expression in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancer.
Hinz S; Pagerols-Raluy L; Oberg HH; Ammerpohl O; Grüssel S; Sipos B; Grützmann R; Pilarsky C; Ungefroren H; Saeger HD; Klöppel G; Kabelitz D; Kalthoff H
Cancer Res; 2007 Sep; 67(17):8344-50. PubMed ID: 17804750
[TBL] [Abstract][Full Text] [Related]
10. Biomarkers of TGF-β signaling pathway and prognosis of pancreatic cancer.
Javle M; Li Y; Tan D; Dong X; Chang P; Kar S; Li D
PLoS One; 2014; 9(1):e85942. PubMed ID: 24465802
[TBL] [Abstract][Full Text] [Related]
11. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
[TBL] [Abstract][Full Text] [Related]
12. A novel 3-dimensional culture system uncovers growth stimulatory actions by TGFβ in pancreatic cancer cells.
Sempere LF; Gunn JR; Korc M
Cancer Biol Ther; 2011 Aug; 12(3):198-207. PubMed ID: 21613822
[TBL] [Abstract][Full Text] [Related]
13. Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
Lee JE; Lee P; Yoon YC; Han BS; Ko S; Park MS; Lee YJ; Kim SE; Cho YJ; Lim JH; Ryu JK; Shim S; Kim DK; Jung KH; Hong SS
Biomed Pharmacother; 2023 Jun; 162():114716. PubMed ID: 37086509
[TBL] [Abstract][Full Text] [Related]
14. Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression.
Ijichi H; Chytil A; Gorska AE; Aakre ME; Fujitani Y; Fujitani S; Wright CV; Moses HL
Genes Dev; 2006 Nov; 20(22):3147-60. PubMed ID: 17114585
[TBL] [Abstract][Full Text] [Related]
15. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
[TBL] [Abstract][Full Text] [Related]
16. Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis.
Pedersen RS; Nissen NI; Jensen C; Thorlacius-Ussing J; Manon-Jensen T; Olesen ML; Langholm LL; Diab HMH; Jorgensen LN; Hansen CP; Chen IM; Johansen JS; Karsdal MA; Willumsen N
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139154
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-4- and interleukin-13-enhanced transforming growth factor-beta2 production in cultured human bronchial epithelial cells is attenuated by interferon-gamma.
Wen FQ; Kohyama T; Liu X; Zhu YK; Wang H; Kim HJ; Kobayashi T; Abe S; Spurzem JR; Rennard SI
Am J Respir Cell Mol Biol; 2002 Apr; 26(4):484-90. PubMed ID: 11919085
[TBL] [Abstract][Full Text] [Related]
18. TGF-β Inhibitors in Metastatic Pancreatic Ductal Adenocarcinoma.
Alvarez MA; Freitas JP; Mazher Hussain S; Glazer ES
J Gastrointest Cancer; 2019 Jun; 50(2):207-213. PubMed ID: 30891677
[TBL] [Abstract][Full Text] [Related]
19. TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.
Thakur AK; Nigri J; Lac S; Leca J; Bressy C; Berthezene P; Bartholin L; Chan P; Calvo E; Iovanna JL; Vasseur S; Guillaumond F; Tomasini R
Cell Death Differ; 2016 Aug; 23(8):1358-70. PubMed ID: 26943320
[TBL] [Abstract][Full Text] [Related]
20. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma.
Yuan Y; Jiang JY; Wang JM; Sun J; Li C; Liu BQ; Yan J; Meng XN; Wang HQ
J Cell Mol Med; 2019 Aug; 23(8):5006-5016. PubMed ID: 31119886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
